Company Filing History:
1 out of 14 
1 out of 5,094 
Years Active: 2008
Title: Eric Prina - Innovator in Quinoline-based Treatment for Protozoa and Retrovirus Co-infections
Introduction:
Meet Eric Prina, an accomplished inventor and researcher hailing from Les Clayes Sous Bois, France. With a strong background in chemistry and pharmaceutical sciences, Prina has made significant contributions to the field of medicine. His groundbreaking patented invention using substituted quinolines for the treatment of protozoa and retrovirus co-infections has shown immense promise in addressing these challenging medical conditions.
Latest Patents:
Eric Prina has an impressive patent portfolio, and his most notable invention is the use of quinolines for the treatment of protozoa and retrovirus co-infections. The patent involves quinolines with a specific chemical formula and includes various substituents that enhance their effectiveness. This innovative treatment has the potential to revolutionize the medical field and improve the therapeutic options available for patients.
Career Highlights:
Throughout his career, Eric Prina has worked with renowned organizations at the forefront of scientific research. He has made significant contributions to the fields of pharmaceutical development and infectious disease treatment. Two notable companies he has worked with include:
1. Institut de Recherche pour le Développement (IRD): Prina's association with IRD allowed him to conduct extensive research and contribute to the advancement of medical knowledge. The IRD is a French research institute focused on addressing pressing global issues, particularly those related to developing countries.
2. Centre National de la Recherche Scientifique (CNRS): Prina also collaborated with CNRS, one of the leading research institutions worldwide. CNRS is renowned for its multidisciplinary approach to scientific exploration and innovation.
Collaborations:
Throughout his career, Eric Prina has collaborated with esteemed scientists to further enhance his research and patent developments. Notably, he has worked alongside Mohamed Fakhfakh and Bruno Figadere. These collaborations have fueled the exchange of ideas, leading to significant breakthroughs in the field of medicine and pharmacology.
Conclusion:
Eric Prina is a distinguished innovator in the field of medicine, particularly in the development of novel treatments for protozoa and retrovirus co-infections. His patented invention using substituted quinolines showcases his expertise in pharmaceutical sciences. Prina's contributions have the potential to transform the way these challenging medical conditions are treated, offering hope for patients around the world. With a remarkable career and a brilliant mind for innovation, Eric Prina continues to push the boundaries of medical science and make a lasting impact in the field of healthcare.